Gablofen Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$203M
Gablofen General Information
Description
Manufacturer of drugs intended to offer medicines for spasticity and pain management. The company offers drugs that treat side effects such as muscle tightness, spasms, fatigue, and frozen and stiff joints.
Contact Information
Website
www.gablofen.com(Operating Subsidiary)
Corporate Office
- 332 North Minnesota
- Street W1750
- Saint Paul, MN 55101
- United States
Corporate Office
- 332 North Minnesota
- Street W1750
- Saint Paul, MN 55101
- United States
Gablofen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 20-Mar-2017 | $203M | Completed | Generating Revenue | ||
| 6. Merger/Acquisition | 03-Oct-2012 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 27-Apr-2011 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 18-Aug-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 26-Jun-2008 | $6M | $8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | $2M | $2M | Completed | Generating Revenue |
Gablofen Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InterWest Health Partners | Corporate Venture Capital | Minority | ||
| InterWest Partners | Venture Capital | Minority | ||
| Mallinckrodt Pharmaceuticals | Corporation | Majority | ||
| Michael J. Fox Foundation | Limited Partner | |||
| Thomas McNerney & Partners | Venture Capital | Minority |
Gablofen FAQs
-
When was Gablofen founded?
Gablofen was founded in 2007.
-
Where is Gablofen headquartered?
Gablofen is headquartered in Saint Paul, MN.
-
What industry is Gablofen in?
Gablofen’s primary industry is Pharmaceuticals.
-
Is Gablofen a private or public company?
Gablofen is a Private company.
-
What is the current valuation of Gablofen?
The current valuation of Gablofen is .
-
What is Gablofen’s current revenue?
The current revenue for Gablofen is .
-
How much funding has Gablofen raised over time?
Gablofen has raised $18.1M.
-
Who are Gablofen’s investors?
InterWest Health Partners, InterWest Partners, Mallinckrodt Pharmaceuticals, Michael J. Fox Foundation, and Thomas McNerney & Partners have invested in Gablofen.
-
When was Gablofen acquired?
Gablofen was acquired on 20-Mar-2017.
-
Who acquired Gablofen?
Gablofen was acquired by Piramal Enterprises.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process